These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2149727)

  • 1. Lithium augmentation in geriatric depression.
    van Marwijk HW; Bekker FM; Nolen WA; Jansen PA; van Nieuwkerk JF; Hop WC
    J Affect Disord; 1990 Dec; 20(4):217-23. PubMed ID: 2149727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lithium in the treatment of depressed elderly patients].
    Bekker FM; van Marwijk HW; Nolen WA; Jansen PA; van Nieuwkerk JF
    Ned Tijdschr Geneeskd; 1990 Mar; 134(9):442-5. PubMed ID: 2314507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoclonus during combined tricyclic antidepressant and lithium treatment.
    Devanand DP; Sackeim HA; Brown RP
    J Clin Psychopharmacol; 1988 Dec; 8(6):446-7. PubMed ID: 3148641
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine-imipramine interaction.
    Leroi I; Walentynowicz MA
    Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression.
    Solomon RL; Rich CL; Darko DF
    J Affect Disord; 1990 Apr; 18(4):253-7. PubMed ID: 2140377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychopharmacologic treatment of major depression.
    Stoudemire A
    J Med Assoc Ga; 1988 Nov; 77(11):821-4. PubMed ID: 3142958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine.
    Strober M; Freeman R; Rigali J; Schmidt S; Diamond R
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):16-20. PubMed ID: 1537769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium augmentation in psychotic depression refractory to combined drug treatment.
    Nelson JC; Mazure CM
    Am J Psychiatry; 1986 Mar; 143(3):363-6. PubMed ID: 2869701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
    Prien RF; Kupfer DJ; Mansky PA; Small JG; Tuason VB; Voss CB; Johnson WE
    Arch Gen Psychiatry; 1984 Nov; 41(11):1096-104. PubMed ID: 6437366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium augmentation in a case of renal impairment: risk vs. benefit.
    Gash AJ; Chhabra S; Eccleston D
    J Affect Disord; 1995 Apr; 34(1):51-3. PubMed ID: 7622739
    [No Abstract]   [Full Text] [Related]  

  • 14. Lithium augmentation for treatment-resistant depression in the elderly.
    Lafferman J; Solomon K; Ruskin P
    J Geriatr Psychiatry Neurol; 1988 Jan; 1(1):49-52. PubMed ID: 3150926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ; McCance SL; Ware CJ; Cohen PR; Chalmers JS; Julier DL
    Br J Psychiatry; 1991 Sep; 159():341-6. PubMed ID: 1659918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcome of lithium added to antidepressants in resistant depression.
    Alvarez E; Pérez-Solá V; Pérez-Blanco J; Queraltó JM; Torrubia R; Noguera R
    J Affect Disord; 1997 Feb; 42(2-3):179-86. PubMed ID: 9105959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium as an adjunct in the treatment of major depression.
    Browne M; Lapierre YD; Hrdina PD; Horn E
    Int Clin Psychopharmacol; 1990 Apr; 5(2):103-10. PubMed ID: 2116474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day.
    Jensen HV; Plenge P; Mellerup ET; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Acta Psychiatr Scand; 1995 Jul; 92(1):69-74. PubMed ID: 7572251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.
    Berghöfer A; Kossmann B; Müller-Oerlinghausen B
    Acta Psychiatr Scand; 1996 May; 93(5):349-54. PubMed ID: 8792904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between patient variables and lithium dosage requirements.
    Lesar TS; Tollefson G; Koch M
    J Clin Psychiatry; 1985 Apr; 46(4):133-6. PubMed ID: 3980451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.